Zoetis Inc. (NYSE:ZTS) Shares Sold by Vinland Capital Management Gestora de Recursos LTDA.

Vinland Capital Management Gestora de Recursos LTDA. trimmed its holdings in Zoetis Inc. (NYSE:ZTS) by 61.0% in the third quarter, Holdings Channel reports. The fund owned 4,865 shares of the company’s stock after selling 7,595 shares during the period. Zoetis accounts for about 2.2% of Vinland Capital Management Gestora de Recursos LTDA.’s portfolio, making the stock its 6th biggest position. Vinland Capital Management Gestora de Recursos LTDA.’s holdings in Zoetis were worth $951,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Prevail Innovative Wealth Advisors LLC lifted its holdings in shares of Zoetis by 24.5% in the first quarter. Prevail Innovative Wealth Advisors LLC now owns 18,977 shares of the company’s stock valued at $3,211,000 after purchasing an additional 3,738 shares in the last quarter. BI Asset Management Fondsmaeglerselskab A S lifted its holdings in shares of Zoetis by 58.6% in the first quarter. BI Asset Management Fondsmaeglerselskab A S now owns 41,931 shares of the company’s stock valued at $7,095,000 after purchasing an additional 15,491 shares in the last quarter. Duality Advisers LP lifted its holdings in shares of Zoetis by 43.7% in the first quarter. Duality Advisers LP now owns 40,641 shares of the company’s stock valued at $6,877,000 after purchasing an additional 12,359 shares in the last quarter. M&G Plc bought a new stake in shares of Zoetis in the first quarter valued at about $19,819,000. Finally, Cetera Investment Advisers lifted its holdings in shares of Zoetis by 275.2% in the first quarter. Cetera Investment Advisers now owns 96,085 shares of the company’s stock valued at $16,259,000 after purchasing an additional 70,476 shares in the last quarter. 92.80% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several analysts recently issued reports on ZTS shares. BTIG Research upped their target price on Zoetis from $220.00 to $225.00 and gave the stock a “buy” rating in a report on Monday, August 12th. Argus upgraded Zoetis to a “strong-buy” rating in a research note on Friday, August 9th. Stifel Nicolaus upped their price objective on Zoetis from $200.00 to $210.00 and gave the company a “buy” rating in a research note on Wednesday, September 18th. JPMorgan Chase & Co. upped their price objective on Zoetis from $225.00 to $230.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. Finally, Piper Sandler upped their price objective on Zoetis from $195.00 to $210.00 and gave the company an “overweight” rating in a research note on Wednesday, August 14th. Ten equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the company has an average rating of “Buy” and a consensus target price of $221.44.

Zoetis Price Performance

Zoetis stock opened at $182.74 on Thursday. Zoetis Inc. has a 12 month low of $144.80 and a 12 month high of $201.92. The stock’s 50 day moving average is $189.02 and its 200-day moving average is $178.28. The company has a current ratio of 3.45, a quick ratio of 2.09 and a debt-to-equity ratio of 1.32. The company has a market capitalization of $82.79 billion, a price-to-earnings ratio of 35.22, a PEG ratio of 2.79 and a beta of 0.89.

Zoetis (NYSE:ZTS) last posted its earnings results on Tuesday, August 6th. The company reported $1.56 EPS for the quarter, beating the consensus estimate of $1.49 by $0.07. Zoetis had a return on equity of 50.67% and a net margin of 26.29%. The company had revenue of $2.36 billion for the quarter, compared to the consensus estimate of $2.31 billion. During the same quarter in the prior year, the business earned $1.41 earnings per share. The firm’s revenue for the quarter was up 8.3% on a year-over-year basis. Equities research analysts expect that Zoetis Inc. will post 5.83 EPS for the current year.

Zoetis Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 3rd. Investors of record on Thursday, October 31st will be given a dividend of $0.432 per share. This represents a $1.73 dividend on an annualized basis and a yield of 0.95%. The ex-dividend date is Thursday, October 31st. Zoetis’s dividend payout ratio is currently 33.14%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.